Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_assertion type Assertion NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_head.
- NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_assertion description "[Moreover, ErbB signaling (including EGFR, ERBB2, ERBB3, ERBB4 and their downstream genes) is the most extensively mutated pathway, affecting 36.8% (21/57) of the GBC samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_provenance.
- NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_assertion evidence source_evidence_literature NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_provenance.
- NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_assertion SIO_000772 24997986 NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_provenance.
- NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_assertion wasDerivedFrom befree-20150227 NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_provenance.
- NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_assertion wasGeneratedBy ECO_0000203 NP381104.RAW7XHMcPkQIDyZANiz1-XdNWKIT-xP-JE8E-Wlh_KNjU130_provenance.